Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-09-08, Stock:ABT, The news for the past five days is as follows:
2020-08-31: NEWS1: The Zacks Analyst Blog Highlights: Verizon Communications, Novartis, Abbott Laboratories, AT&T, Intuitive Surgical and Northrop Grumman.NEWS2: The Zacks Analyst Blog Highlights: Abbott Lab, Quidel, Becton, Dickinson and Company, Hologic and Quest Diagnostics.NEWS3: Coronavirus Impact on Consumer Behavior.NEWS4: Abbott Analyst: Expert View On Rapid Coronavirus Antigen Test 'Clearly Bullish'.
2020-09-01: NEWS1: Analyst Report: Abbott Laboratories.NEWS2: Here’s what to know about Abbott’s 15-minute COVID-19 test.NEWS3: In Canada, airlines face uphill climb to replace quarantines with COVID-19 testing.NEWS4: U.S. to send millions of rapid COVID-19 tests to states to support school reopening, other tasks.NEWS5: Why Abbott Stock Is Up.NEWS6: Abbott's FreeStyle® Libre 2 iCGM System Now Available to Medicare Beneficiaries.
2020-09-02: NEWS1: Abbot Labs: New COVID-19 Antibody Test Is a Game Changer, Says Analyst.NEWS2: 'Halftime Report' Traders Weigh In On DraftKings, Beyond Meat And More.NEWS3: Why Co-Diagnostics Shares Sank Today While the Stock Market Jumped.NEWS4: Roche Stock Is Rising Because the Company Has a Covid-19 Antigen Test.NEWS5: Trump administration sending rapid COVID tests to states, CDC bars evictions.
2020-09-03: NEWS1: Medicare Coverage for Libre 2 Boosts Abbott's CGM Prospects.NEWS2: Abbott Announces Start of Trial to Evaluate the New Esprit™ BTK Drug-Eluting Resorbable Scaffold.NEWS3: Fulgent Shares Up 10% On COVID-19 Testing Deal For New York Schools.
2020-09-04: NEWS1: Abbott (ABT) Dips More Than Broader Markets: What You Should Know.NEWS2: Quick Virus Testing, Traffic Trends, Bring Hope for Airlines.NEWS3: The Zacks Analyst Blog Highlights: Medtronic, Abbott Laboratories, Myriad Genetics, Zimmer Biomet and General Electric.NEWS4: Next Coronavirus Market Crash: Where to Invest $1,000.

Answer: Decrease